SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-24-048464
Filing Date
2024-02-27
Accepted
2024-02-27 21:00:28
Documents
1
Group Members
JAMES HUANGPANACEA VENTURE HEALTHCARE FUND II GP CO LTD.PANACEA VENTURE HEALTHCARE FUND II L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d785358dsc13da.htm SC 13D/A 81843
  Complete submission text file 0001193125-24-048464.txt   83633
Mailing Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address 12265 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130 858-727-1040
Connect Biopharma Holdings Ltd (Subject) CIK: 0001835268 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92416 | Film No.: 24689744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PANACEA VENTURE, NO. 5, LANE 1350 FUXING MIDDLE ROAD SHANGHAI F4 200031
Business Address C/O PANACEA VENTURE, NO. 5, LANE 1350 FUXING MIDDLE ROAD SHANGHAI F4 200031 86 21 60252100
Panacea Innovation Ltd (Filed by) CIK: 0002010692 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A